bionomics.com.au (BNOX) - מקדם חוב לטווח ארוך להון

Bionomics Limited (BNOX) is a biotech startup developing anxiety treatments whose future pricing power relies on exclusive patents. The business is based on flexible international raw material supplies and collaborations with various research centers to minimize risks. The share price history, where the indicator is 0.01, demonstrates a dependence on clinical trial outcomes amid a lack of current sales and high R&D costs.

This indicator compares liabilities with maturities exceeding one year against current market capitalization to assess financial stability. For Bionomics Limited (BNOX), such a debt structure is justified by the development of innovative drugs for PTSD and anxiety disorders. Analyzing the ratio of long-term debt to equity reveals the balance between credit risks and expansion. An increase in this metric reflects investments in scaling the business, serving as a key marker of solvency during aggressive growth.